Suthinee Jaruvongvanich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suthinee Jaruvongvanich has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Veeravich Jaruvongvanich
Internal Medicine, University of Hawaii, Honolulu, HI
5 shared publications - Anawin Sanguankeo
Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
4 shared publications - Sikarin Upala
Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
4 shared publications Weeranuch Rattanadech
1 shared publicationWilawan Damkerngsuntorn
1 shared publicationYongkasem Vorasettakarnkij
1 shared publication
Latest Publications
- 1 May 2016
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 7, 92-97
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis
- 1 May 2016
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 7, 92-97
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1026-S1027
351 Association Between Systemic Inflammatory Response Syndrome and Mortality in Hospitalized Patients With Alcoholic Hepatitis: A Systematic Review and Meta-Analysis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1026-S1027
351 Association Between Systemic Inflammatory Response Syndrome and Mortality in Hospitalized Patients With Alcoholic Hepatitis: A Systematic Review and Meta-Analysis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1031-S1032
421 Caffeine is Associated with Decreased Risk of Advanced Hepatic Fibrosis in Patients with Chronic Hepatitis C: A Systematic Review and Meta-Analysis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1031-S1032
421 Caffeine is Associated with Decreased Risk of Advanced Hepatic Fibrosis in Patients with Chronic Hepatitis C: A Systematic Review and Meta-Analysis
- 3 March 2016
- Published by Wiley in World Journal of Surgery
- Vol. 40 (11) , 2816-2817
Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta‐analysis
- 3 March 2016
- Published by Wiley in World Journal of Surgery
- Vol. 40 (11) , 2816-2817
Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta‐analysis
- 1 October 2015
- Vol. 98 (10) , 935-41
CK-MB Activity, Any Additional Benefit to Negative Troponin in Evaluating Patients with Suspected Acute Myocardial Infarction in the Emergency Department.
Coronary heart disease is now the leading cause of death. Diagnosing myocardial infraction (MI) needs cardiac marker in case of equivocal clinical presentations and EKG interpretations. Troponin yields high sensitivity and specificity and could be used as a single screening assay. However, in actual practice, clinicians send CK-MB activity (CKMBa) as a combined marker with an expectation of providing additional diagnostic value due to large historical data. Discordant results from both markers lead to unclear management. Our study was to determine whether CKMBa has potential benefit for initial screening of MI in addition to cardiac troponin T (cTpT) in the Emergency Department (ED), and can this marker be safely removed from the routine laboratory panel in the emergency setting in Thailand. We conducted a retrospective cohort single-center study to examine the usefulness of CKMBa in the ED from 907 patients who presented with clinically suspected acute M, and investigated with both biomarkers (CKMBa and cTpT). In these patients, 97 patients were included in the final analysis as they had negative cTpT associated with positive CKMBa or CKMBa turned to be positive within 24 hours after serial biomarkers measurements. The outcome was assessed by the final diagnosis, the cause of death if patients died during admission, and the 180-day mortality from medical chart review. In patients highly suspectedfor MI, further investigations were done including echocardiogram, exercise stress test, and coronay angiogram by experienced cardiologists. During the studyperiod, cTpTwere sent 1,772 times and most (95.2%) ofthe samples were associated with CKMBa results. The outcome showed that no one with negative cTpT was diagnosed as MI on a discharge diagnosis. Fourteen patients died during admission. The definitive cause was not defined as MI. The 180-day mortality was zero. During the follow-up, there was no MI suspected issues that needed further cardiac evaluations. The positive predictive value of CKMBa with negative cTpT was 0% (95% CI, 0-0.047). CKMBa added no benefit to cTpT in diagnosing acute MI in ED. Removing CKMBa from emergency panel could be considered.
- 1 October 2015
- Vol. 98 (10) , 935-41
CK-MB Activity, Any Additional Benefit to Negative Troponin in Evaluating Patients with Suspected Acute Myocardial Infarction in the Emergency Department.
Coronary heart disease is now the leading cause of death. Diagnosing myocardial infraction (MI) needs cardiac marker in case of equivocal clinical presentations and EKG interpretations. Troponin yields high sensitivity and specificity and could be used as a single screening assay. However, in actual practice, clinicians send CK-MB activity (CKMBa) as a combined marker with an expectation of providing additional diagnostic value due to large historical data. Discordant results from both markers lead to unclear management. Our study was to determine whether CKMBa has potential benefit for initial screening of MI in addition to cardiac troponin T (cTpT) in the Emergency Department (ED), and can this marker be safely removed from the routine laboratory panel in the emergency setting in Thailand. We conducted a retrospective cohort single-center study to examine the usefulness of CKMBa in the ED from 907 patients who presented with clinically suspected acute M, and investigated with both biomarkers (CKMBa and cTpT). In these patients, 97 patients were included in the final analysis as they had negative cTpT associated with positive CKMBa or CKMBa turned to be positive within 24 hours after serial biomarkers measurements. The outcome was assessed by the final diagnosis, the cause of death if patients died during admission, and the 180-day mortality from medical chart review. In patients highly suspectedfor MI, further investigations were done including echocardiogram, exercise stress test, and coronay angiogram by experienced cardiologists. During the studyperiod, cTpTwere sent 1,772 times and most (95.2%) ofthe samples were associated with CKMBa results. The outcome showed that no one with negative cTpT was diagnosed as MI on a discharge diagnosis. Fourteen patients died during admission. The definitive cause was not defined as MI. The 180-day mortality was zero. During the follow-up, there was no MI suspected issues that needed further cardiac evaluations. The positive predictive value of CKMBa with negative cTpT was 0% (95% CI, 0-0.047). CKMBa added no benefit to cTpT in diagnosing acute MI in ED. Removing CKMBa from emergency panel could be considered.